4th Circuit Dupixent news shows skin cancer cases across North Carolina, South Carolina, Maryland, Virginia, and West Virginia. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims.
To learn more, please see our information on claiming a 4th Circuit Dupixent settlement.
North Carolina Dupixent News
North Carolina Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- NC Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a North Carolina Dupixent lawsuit.
South Carolina Dupixent News
South Carolina Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- SC Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a South Carolina Dupixent lawsuit.
Maryland Dupixent News
Maryland Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- MD Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Maryland Dupixent lawsuit.
Virginia Dupixent News
Virginia Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- VA Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Virginia Dupixent lawsuit.
West Virginia Dupixent News
West Virginia Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- WV Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a West Virginia Dupixent lawsuit.
4th Circuit Dupixent News Supports MDL Settlement for Skin Cancer
4th Circuit Dupixent news of T-cell lymphoma has raised concerns for eczema and asthma patients in North Carolina, South Carolina, Maryland, Virginia, and West Virginia. As such, public support is growing for the court’s certification of a Dupixent Multi-District Litigation (MDL) to administer claims.
Lymphoma Attorneys Act on 4th Circuit Dupixent News of Skin Cancer
Reporting skin cancer is an important first step to justice. If your family has been impacted by Dupixent, contact us about filing a 4th Circuit settlement claim.
For background information on T-cell lymphoma, please see our Dupixent lawyers homepage.